Drug Type Gene editing |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization DiNAQOR AGStartup |
Active Organization DiNAQOR AGStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart failure with reduced ejection fraction | Preclinical | CH | DiNAQOR AGStartup | 10 Jan 2022 |